Johnson & Johnson
A healthcare maker of prescription medicines — treatments for cancer, immune and nerve conditions, including DARZALEX and STELARA — plus medical devices such as ACUVUE contact lenses and surgical tools. Three Johnson brothers founded it in 1886 in New Jersey, inspired by a lecture on antiseptic surgery. Fun fact: an employee created BAND-AID bandages in 1920 for his wife, who kept cutting herself while cooking.
Granted 84.7K · Sold 100.0K
Granted 88.6K · Sold 56.5K
Granted 64.5K · Sold 10.0K
Granted 107.8K · Sold 89.7K
Granted 73.1K · Sold 62.1K
Granted 101.8K · Sold 75.7K
Granted 7.8K · Sold 4.1K
Granted 45.1K · Sold 23.9K
Granted 36.8K
Granted 10.0K · Sold 6.2K
Granted 10.6K
Bought 1.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Duato JoaquinCEO and Chairman of the Board, Director · 10 transactions | +5.6% | 911.2K | 84.7K | — | 100.0K |
| Taubert Jennifer LEVP, WWC. Innovative Medicine · 10 transactions | +14.1% | 194.5K | 88.6K | — | 56.5K |
| Wengel Kathryn EEVP, Chief TO and Risk Officer · 12 transactions | +36.7% | 124.7K | 64.5K | — | 10.0K |
| Wolk Joseph JExec VP, CFO · 15 transactions | +8% | 110.0K | 107.8K | — | 89.7K |
| Swanson James D.EVP, CIO · 14 transactions | +178.1% | 46.2K | 73.1K | — | 62.1K |
| Reed John CEVP, Innovative Medicine, R&D · 13 transactions | +237% | 35.9K | 101.8K | — | 75.7K |
| Decker Robert JVP Corporate Controller · 10 transactions | +31.2% | 28.5K | 7.8K | — | 4.1K |
| Schmid TimothyEVP, WW Chair, MedTech · 15 transactions | +65.4% | 26.2K | 45.1K | — | 23.9K |
| Forminard ElizabethEVP, Chief Legal Officer · 12 transactions | +135.1% | 23.5K | 36.8K | — | — |
| Broadhurst VanessaEVP, Global Corp Affairs · 9 transactions | +6.1% | 23.0K | 10.0K | — | 6.2K |
| Mulholland KristenEVP, Chief HR Officer · 10 transactions | +51.7% | 19.7K | 10.6K | — | — |
| Morikis John GDirector · 1 transaction | — | 1.8K | — | 1.3K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -426.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.